#India #Arjuna Natural #Shoden ashwagandha #stress relief #Jhansi

The Breakthrough of Shoden® Ashwagandha in Stress Management

In a world where stress and anxiety have escalated, especially post-COVID, people are increasingly turning towards natural remedies for relief. Among these, the adaptogenic herb ashwagandha, scientifically known as Withania somnifera, has long been esteemed for its calming properties. Recent research from Arjuna Natural Pvt. Ltd. reinforces the efficacy of this ancient herb, especially when delivered through their proprietary Shoden® ashwagandha extract.

A New Study on Stress Relief

Published in the peer-reviewed journal Heliyon in September 2024, a new double-blind, placebo-controlled study conducted at Nirmal Hospital in Jhansi, India, has unveiled intriguing findings regarding ashwagandha. The study involved 60 healthy individuals experiencing above-normal levels of stress and anxiety. Participants were given daily doses of Shoden® in either 60mg or 120mg over a 60-day period. The results were significant: those taking Shoden® exhibited a remarkable 59% reduction in anxiety levels as measured by the Hamilton Anxiety Rating Scale (HAMA).

More impressively, morning cortisol levels, which play a critical role in the body's stress response, dropped by 66% and 67% in the Shoden groups. In contrast, the placebo cohort only showed a minimal change of 2.2%. Additionally, the study revealed enhanced testosterone levels in male participants using Shoden®, indicating a broader positive impact on men's health.

Shoden®: Unraveling the Science

The extract known as Shoden® is characterized by its high concentration of withanolide glycosides, precisely standardized to 35%. Withanolides are a key group of phytochemicals found in ashwagandha known for their potent antioxidant, anti-inflammatory, and stress-relieving properties.

The leading researcher, Deo Nidhi Mishra, underscored the advancement this study represents in understanding how low-dose Shoden® can alleviate stress and anxiety. Benny Antony, PhD, Joint Managing Director at Arjuna, emphasized the implication of such beneficial outcomes achieved at such low doses, showcasing the innovative work of their research team.

The findings align with earlier studies that have already shown promising results with higher doses of Shoden. Notably, withanolide glycosides assist in modulating the hypothalamic-pituitary-adrenal (HPA) axis, consequently regulating cortisol levels and the associated feelings of anxiety.

The Importance of Safety and Sustainability

Arjuna Natural emphasizes ethical practices in sourcing their ashwagandha. Shoden® is produced from sustainably harvested roots and leaves, ensuring zero waste and optimal returns for the farmers involved in the supply chain. Extensive safety studies have been conducted to validate the extract's safety profile, with ongoing clinical trials to confirm its long-term safety on human subjects.

This commitment to both safety and sustainability is underpinned by a robust backing of 11 studies and 23 patents related to the formulation and production methods of Shoden®.

Arjuna Natural is more than just a manufacturer; they actively empower local farmers through training in Good Agricultural Practices (GAP), fostering healthy agricultural ecosystems while supporting the cultivation of high-quality ashwagandha.

Conclusion

With the growing global interest in natural approaches to managing stress and anxiety, Arjuna's Shoden® ashwagandha emerges as a beacon of hope. This innovative formulation not only embraces the wisdom of traditional herbal medicine but also stands on the solid foundation of modern scientific research. As Arjuna Natural continues to pave the way in the nutraceutical sector, Shoden® could very well become a valued ally for those seeking peace in today’s hectic world.